NASDAQ : ELUT
Elutia Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.8371 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 37.07M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 36.36M |
| Enterprise Value | 20.85M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 44.29M |
| Shares Outstanding | 44.29M |
| Shares Change (YoY) | +22.72% |
| Shares Change (QoQ) | +2.85% |
| Owned by Insiders (%) | 3.75% |
| Owned by Institutions (%) | 13.58% |
| Float | 29.48M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 0.82 |
| Forward PE | n/a |
| PS Ratio | 3.05 |
| Forward PS | 18.54 |
| PB Ratio | 2.35 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 0.42 |
| EV / Sales | 1.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.77 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -34.66% |
| Return on Invested Capital (ROIC) | -411.71% |
| Return on Capital Employed (ROCE) | -95.06% |
| Weighted Average Cost of Capital (WACC) | 7.92% |
| Revenue Per Employee | $466,769 |
| Profits Per Employee | $1.99M |
| Employee Count | 26 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.30 |
Taxes
| Measure | Value |
|---|
| Income Tax | 75,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -9.72% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 0.97 |
| Relative Strength Index (RSI) | 50.42 |
| Average Volume (20 Days) | 101,229 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 15,326 |
| Short Previous Month | 9,359 |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | 0.04 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 12.14M |
| Gross Profit | 7.01M |
| Operating Income | -21.49M |
| Pretax Income | -22.36M |
| Net Income | 51.81M |
| EBITDA | -21.35M |
| EBIT | -21.49M |
| Earnings Per Share (EPS) | $1.01 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 19.90M |
| Total Debt | 4.38M |
| Net Cash | 15.52M |
| Net Cash Per Share | $0.35 |
| Equity (Book Value) | 15.75M |
| Book Value Per Share | 0.36 |
| Working Capital | 16.17M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -43.99M |
| Capital Expenditures | -2.03M |
| Depreciation & Amortization | 135,000 |
| Net Borrowing | -23.06M |
| Free Cash Flow | -46.03M |
| FCF Per Share | -$1.04 |
Margins
| Measure | Value |
|---|
| Gross Margin | 57.76% |
| Operating Margin | -177.06% |
| Pretax Margin | -184.23% |
| Profit Margin | 426.90% |
| EBITDA Margin | -175.95% |
| EBIT Margin | -177.06% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -22.72% |
| Shareholder Yield | -22.72% |
| Earnings Yield | 122.52% |
| FCF Yield | -124.15% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -5.97 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |